Press release
Mumps Vaccine (MumpsVax) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Mumps Vaccine (MumpsVax) Market
In recent times, the market for the mumps vaccine, mumpsvax, has significantly expanded. The market is projected to grow from a value of $2,057.93 million in 2024 to $2,210.59 million in 2025, translating to a compound annual growth rate (CAGR) of 7.4%. The upward trend during the historical period can be credited to higher rates of vaccinations amongst children, a surge in global health initiatives, greater public confidence in vaccines, heightened travel cognizance, and an upsurge in immunization drives.
There is an anticipated significant increase in the mumps vaccine (mumpsvax) market size in the coming years. The projected growth is estimated to reach $2,902.21 million in 2029 with a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is primarily due to factors such as increased incidences of diseases preventable by vaccines, heightened awareness about adult vaccination, growing health consciousness, expansion of immunization programs, and greater international health efforts. The forecast period is likely to see key trends such as personalized vaccination plans, incorporation of digital health, improved surveillance systems, research and development in adult vaccination, and the inclusion of artificial intelligence.
What Is Contributing to the Growth of the Mumps Vaccine (MumpsVax) Market?
The growing incidence of infectious diseases is anticipated to fuel the mumps vaccine (mumpsvax) market's expansion. Infectious diseases, caused by harmful microorganisms such as viruses, bacteria, fungi or parasites, can be spread person to person or via polluted surroundings. Factors like urbanization, climate alteration, globalization and shifts in human demographics and behavior that enhance the transmission of pathogens primarily drive their prevalence. Mumpsvax, a vaccine against mumps infection (an infectious disease caused by mumps virus), is usually included in the MMR (measles, mumps, rubella) immunization. For instance, as per a report by the UK Health Security Agency in 2024, during 2023, the West Midlands region reported the highest measles cases, recording 160 (44%), trailed by London with 122 (33%). Importantly, children aged 10 or under composed 63% of the total cases, reaching 232 cases. There was a noticeable increase in measles activity towards the year's close, with 157 new cases marked in December, contrasting with just 45 cases in November. Hence, increasing infectious diseases prevalence is propelling the mumps vaccine (mumpsvax) market. An Expected Surge In Healthcare Spending To Improve Mumpsvax Accessibility And Vaccination Rates
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
Which Key Market Leaders Are Driving Mumps Vaccine (MumpsVax) Industry Growth?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
What Are the Main Segments in the Mumps Vaccine (MumpsVax) Market?
The mumps vaccine (mumpsvax)market covered in this report is segmented -
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
Which Geographic Area Leads the Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Mumps Vaccine (MumpsVax) Global Market Report?
- Market Size Analysis: Analyze the mumps vaccine (mumpsvax) Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the mumps vaccine (mumpsvax) market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall mumps vaccine (mumpsvax) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the mumps vaccine (mumpsvax) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumps Vaccine (MumpsVax) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3872889 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greater…
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine,…
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren …
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads…
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 – …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as…
Mumps Market Estimated to Flourish by 2016 – 2024 : Persistence Market Researc …
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands. The disease is transmitted from one person to the other through saliva and/or droplets. Although the symptoms vanish within few days of infection and are usually…
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.…
